Integrin alpha v beta 6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus

Moore, KM; Desai, A; Delgado, BD; Trabulo, SMD; Reader, C; Brown, NF; Murray, ER; Brentnall, A; Howard, P; Masterson, L; Zammarchi, F; Hartley, JA; van Berkel, PH; Marshall, JF

Marshall, JF (corresponding author), Queen Mary Univ London, Ctr Tumour Biol, John Vane Sci Ctr, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England.

THERANOSTICS, 2020; 10 (7): 2930

Abstract

Goals of investigation: The 5-year survival rate for pancreatic ductal adenocarcinoma (PDAC) has remained at <5% for decades because no effective t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索